Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BMS Appoints Oncology Development Head | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

BMS Appoints Oncology Development Head

Namouni to lead pipeline development strategy

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Fouad Namouni, M.D., has been appointed Oncology Development Head, Bristol-Myers Squibb, responsible for leading a comprehensive development strategy for the company’s oncology pipeline from early development through commercialization. He will continue to report to Francis Cuss, MB Bchir, FRCP, executive vice president, chief scientific officer, and remain a member of the R&D Leadership Team.

Most recently, Dr. Namouni served as head of Medical, leading the worldwide medical organization and prior to that, was the development lead for Yervoy and Opdivo. Dr. Namouni joined Bristol-Myers Squibb in France in 1999 as life-cycle manager for Taxol and has held positions of increasing responsibility in R&D since.    

“Fouad has demonstrated highly successful strategic and visionary leadership in oncology and immuno-oncology drug development and medical affairs throughout his career at Bristol-Myers Squibb,” said Mr. Cuss. “As a trained pediatric oncologist, Fouad brings to this role exceptional clinical experience and an unwavering commitment to patients. I am confident that our oncology development programs will continue to thrive under his leadership.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics